[1] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[2] CHEN SS,WU SX,WANG YL,et al.Expression of p16 and CUL4 B in cervical intraepithelial neoplasia and squamous cell carcinoma[J].Shandong Medical Journal,2017,57(39):53-55.[陈珊珊,吴淑霞,王永利,等.宫颈上皮内瘤变及宫颈鳞癌组织中p16、CUL4 B表达观察[J].山东医药,2017,57(39):53-55.]
[3] CHEN W,ZHAO Y.Expression and significance of p63 and Ki67 in cervical intraepithelial neoplasia(CIN) and cervical cancer[J].Modern Oncology,2017,25(2):273-275.[陈玮,赵涌.p63和Ki67在CIN及宫颈癌组织中的表达及意义[J].现代肿瘤医学,2017,25(2):273-275.]
[4] Nicolas W,Magnus VKD.Biomarkers in cervical cancer screening[J].Disease Markers,2007,23(4):315-330.
[5] Zhang T,Mao SH,Tang LD,et al.Expression of p16 and human papillomavirus L-1 caspid protein in cervical intraepithelial neoplasia and early cervical carcinoma and their relationship to viral load of high-risk human papillomavirus[J].Journal of Practical Obstetrics and Gynecology,2016,32(7):536-539.[张涛,毛世华,唐良萏,等.宫颈上皮内瘤变及早期宫颈癌组织中p16、HPVL-1壳蛋白的表达及与HR-HPV载量相关性研究[J].实用妇产科杂志,2016,32(7):536-539.]
[6] Kanthiya K,Khunnarong J,Tangjitgamol S,et al.Expression of the p16 and Ki-67 in cervical squamous intraepithelial lesions and cancer[J].Asian Pac J Cancer Prev,2016,17(7):3201-3206.
[7] Costa LBE,Triglia RM,Andrade LALA.p16INK4a,Cytokeratin 7,and Ki-67 as potential markers for low-grade cervical intraepithelial neoplasia progression[J].J Low Genit Tract Dis,2017,21 (3):171-176.
[8] YANG J,ZHOU DP,WANG B,et al.Correlation between p16 and HR-HPV load in cervical intraepithelial neoplasia[J].Journal of Practical Obstetrics and Gynecology,2014,30(1):43-45.[杨君,周德平,王彬,等.宫颈上皮内瘤变组织中p16蛋白表达与HR-HPV病毒载量的相关性研究[J].实用妇产科杂志,2014,30(1):43-45.]
[9] YIN YX,ZHAO H,LIANG J,et al.Study of predictive value for detection of high-grade cervical intraepithelial neoplasia by p16 / Ki-67 dual-stained liquid-based cytology[J].Clin Exp Pathol,2017,33(3):282-286.[印永祥,赵华,梁洁,等.细胞免疫化学p16/Ki-67双染预测子宫颈上皮内高级别瘤变[J].临床与实验病理学杂志,2017,33(3):282-286.]
[10] JIAN Y,LIAO Y,ZENG DM,et al.Expression and clinical significance of TK1,Ki-67 and p16 in cervical intraepithelial neoplasia and cervical cancer[J].Chinese Journal of Diagnostic Pathology,2016,23(10):789-791.[简燚,廖媛,曾冬梅,等.TK1、Ki-67和p16在宫颈上皮内瘤变和宫颈癌中的表达及临床意义[J].诊断病理学杂志,2016,23(10):789-791.]
[11] LIANG XY,YAO H,ZHANG WL.Significance of p16Ki-67 semi-quantitative immunohistochemical score in the diagnosis of cervical intraepithelial neoplasia[J].山西医药杂志,2016,45(6):705-709.[梁晓燕,姚宏,张王亮,等.p16Ki-67免疫组织化学半定量评分在宫颈上皮内瘤变诊断中的意义[J].Shanxi Medical Journal,2016,45(6):705-709.]
[12] YI W,ZHANG ZX,WU Q,et al.Correlation between IMP3,Ki-67,p16INK4a expressions and occurrence and development of cervical intraepithelial neoplasia[J].Maternal and Child Health Care of China,2015,30(25):4379-4381.[易韦,张著学,吴倩,等.IMP3、Ki-67和p16INK4a表达与宫颈上皮内瘤变发生发展相关性[J].中国妇幼保健,2015,30(25):4379-4381.]
[13] Cortecchia S,Galanti G,Sgadari C,et al.Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16INK4a[J].Int J Gynecol Cancer,2013,23(9):1663-1639.
[14] Kisser A,Zechmeister-Koss I.A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology[J].Bjog,2015,122(1):64-70.
[15] Calil LN,Edelweiss MI,Meurer L,et al.p16INK4a and Ki-67 expression in normal,dysplastic and neoplastic uterine cervical epithelium and human papillomavirus (HPV) infection[J].Pathol Res Pract,2014,210(8):482-487.
[16]LI YY,ZHANG XW,WANG H,et al.Value of p16/Ki-67 double staining in differentiating cervical LSIL from HSIL[J].Maternal and Child Health Care of China,2018,33(5):1194-1197.[李洋洋,张曦文,王贺,等.p16/Ki-67双染在区分宫颈LSIL与HSIL中的价值[J].中国妇幼保健,2018,33(5):1194-1197.]
[17] Mulvany NJ,Allen DG,Wilson SM.Diagnostic utility of p16INK4a:A reappraisal of its use in cervical biopsies[J].Pathology,2008,40(4):335-344.
[18] Bergeron C,Ikenberg H,Sideri M,et al.Prospective evaluation of p16/Ki- 67 dual-stained cytology for managing women with abnormal Papanicolaou cytology:PALMS study results[J].Cancer Cytopathol,2015,123(6):373-381.
[19] GE XF,ZHANG RY,YOU K,et al.Valuation of p16/Ki-67 dual-stained cytology for detecting cervical precancerous disease[J].Chinese Journal of Family Planning,2017,25(12):855-859.[葛雪飞,张睿怡,游珂,等.p16/Ki-67双染在宫颈病变检出中的作用[J].中国计划生育学杂志,2017,25(12):855-859.]
[20] Luttmer R,Dijkstra MG,Snijders PJF,et al.p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population[J].Mod Pathol,2016,29(8):870-878.
[21] Jr WT,Behrens CM,Ranger-Moore J,et al.Triaging HPV-positive women with p16/Ki-67 dual-stained cytology:Results from a sub-study nested into the ATHENA trial[J].Gynecologic Oncology,2017,144(1):51-56.
[22] ZHANG JQ,ZHU P,LU MH,et al.Study on immunocytochemistry p16/Ki-67 double staining combined with DNA ploidy analysis for analyzing and predicting cervical high grade squamous intraepithelial lesion[J].Chongqing Medicine,2017,46(13):1770-1772.[张金秋,朱萍,陆敏华,等.细胞免疫化学p16/Ki-67双染结合DNA倍体分析预测HSIL的研究[J].重庆医学,2017,46(13):1770-1772.]
[23] SHI K,LV XQ.The use of p16/Ki-67 double-staining in diagnosis of cervical intraepithelial lesion[J].Journal of Diagnostics Concepts & Practice,2016,15(6):602-607.[石克,吕新全.p16、Ki-67双染在子宫颈上皮内病变病理诊断和分级中的应用[J].诊断学理论与实践,2016,15(6):602-607.]
[24] Das D,Sengupta M,Basu K,et al.Role of p16/Ki-67 dual immunostaining in detection of cervical cancer precursors[J].J Cytol,2018,35(3):153-158.
[25]Pirtea L,Secosan C,Margan M,et al.p16/Ki-67 dual staining has a better accuracy than human papillomavirus (hpv) testing in women under 30 years old[J].Bosn J Basic Med Sci,2018,12(2):446-450.
[26]Leeman A,Pirog EC,Doorbar J,et al.Presence or absence of significant hpve4 expression in high-grade anal intraepithelial neoplasia with p16/Ki-67 positivity indicates distinct patterns of neoplasia:A study combining immunohistochemistry and laser capture microdissection pcr[J].Am J Surg Pathol,2018,42(4):463-471.
[27]Celewicz A,Celewicz M,Wezowska M,et al.Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer[J].Pol J Pathol,2018,69(1):42-47.
[28]Das D,Sengupta M,Basu K,et al.Role of p16/Ki-67 dual immunostaining in detection of cervical cancer precursors[J].J Cytol,2018,35(3):153-158.
[29]Maebayashi T,Ishibashi N,Aizawa T,et al.Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma[J].Eur Arch Otorhinolaryngol,2019,276(4):1221-1229.
[30]Prigenzi KCK,Heinke T,Salim RC,et al.Dual p16 and Ki-67 expression in liquid-based cervical cytological samples compared to pap cytology findings,biopsies,and hpv testing in cervical cancer screening:A diagnostic accuracy study[J].Acta Cytol,2018,62(2):104-114.
[31]Wentzensen N,Clarke MA,Bremer R,et al.Clinical evaluation of human papillomavirus screening with p16/Ki-67 dual stain triage in a large organized cervical cancer screening program[J].JAMA Intern Med,2019,179(7):881-888.
[32]Xu SX,Lin JS,Zhan YM.Value of p16/Ki-67 dual-staining immunocytochemistry in cervical cancer screening[J].Chinese Journal of Pathology,2018,47(3):207-208.
[33]Zhang SK,Jia MM,Zhao DM,et al.Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in china[J].Cancer Epidemiol,2019(59):123-128.